Release Date: 21/01/09 12:01 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 26.99KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%